UFP Technologies Announces CEO Succession Plan
UFP Technologies (Nasdaq: UFPT) announced a planned CEO succession: R. Jeffrey Bailly will retire as CEO at the company’s next annual meeting on June 4, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
UFP Technologies (Nasdaq: UFPT) announced a planned CEO succession: R. Jeffrey Bailly will retire as CEO at the company’s next annual meeting on June 4, 2026. At that time, President Mitchell Rock will become CEO and join the Board, while Bailly will serve as Executive Chairman for one year to facilitate the transition.
The release notes Bailly’s 31-year tenure, company expansion to operations in five countries, a workforce of nearly 5,000 associates, and historical growth of about 20-fold revenue and >150-fold profitability and market capitalization under his leadership.
Positive
- Succession date set for June 4, 2026
- Internal promotion: President Mitch Rock to become CEO and join the Board
- Transition plan includes Bailly as Executive Chairman for one year
- Scale: operations in five countries and nearly 5,000 associates
- Historical growth: ~20-fold revenue increase during Bailly’s tenure
Negative
- Leadership change after a 31-year CEO tenure could disrupt operations during transition
Details
News Market Reaction – UFPT
On Dec 2, the day this news came out, UFPT closed 1.11% below the previous close.
Data tracked by StockTitan Argus for the Dec 2 session.
Key Figures
- CEO transition date
- June 4, 2026
- Planned retirement date for current CEO at annual meeting
- CEO tenure
- 31 years
- Length of R. Jeffrey Bailly’s service as CEO
- Global footprint
- 5 countries
- Company locations during Bailly’s tenure
- Workforce size
- nearly 5,000 associates
- Employee base highlighted in succession release
- Revenue growth multiple
- 20-fold
- Revenue increase during Bailly’s leadership
- Profitability & market cap growth
- more than 150-fold
- Profitability and market capitalization increase under Bailly
- Partnership length
- 25 years
- Duration of strategic partnership between Bailly and Rock
- Executive Chairman term
- 1 year
- Planned period Bailly will serve as Executive Chairman
Historical Context
-
Announced CEO retirement in 2026 with planned transition to President.
-
Disclosure of participation and 1x1 meetings at healthcare conference.
-
Reported strong Q3 2025 sales and earnings with medical growth.
-
Announced timing and access details for Q3 2025 results call.
-
Outlined upcoming presentation at Midwest IDEAS investor conference.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
contract development and manufacturing organization technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEWBURYPORT, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced that R. Jeffrey Bailly will retire as CEO at the Company’s next annual meeting on June 4, 2026. At that time, Mitchell Rock, President of the Company, will assume the CEO position and join the Company’s Board. To facilitate a smooth transition, Mr. Bailly will serve as Executive Chairman of the Board for the following year.
“Serving as CEO for 31 years, Jeff has been an extremely effective leader who, together with his team, transitioned the company to a leading global contract development and manufacturing organization focused on medical markets, with locations in five countries,” said Dan Croteau, Lead Director of the Board. “During Jeff’s tenure, the Company’s revenue grew approximately 20-fold, and profitability and market capitalization grew more than 150-fold. We thank Jeff for his significant contributions, wish him all the best in his retirement, and look forward to his continued impact as Executive Chairman.”
“It has been my honor to lead the exceptional, innovative, and customer-focused team at UFP Technologies, whose dedication, hard work, and can-do attitude have made it the success it is today,” said Bailly. “I am extremely proud of this team of nearly 5,000 associates and all they have done, and continue to do, to make our customers successful. I am very grateful to all of them and to our Board of Directors. I am also very excited about the future of the company under Mitch Rock’s leadership. He has been a strategic partner for 25 years and is a very capable leader who is well-respected throughout our industry. With his deep understanding of the markets we serve, his strong relationships with our key customers and vendor partners, and the trust and respect of his co-workers, Mitch is the natural choice to be UFP’s next CEO.”
“I’m honored by the Board’s confidence and grateful for Jeff’s leadership and mentorship over many years,” said Mitch Rock, President. “As he transitions to Executive Chairman, I look forward to continuing our close partnership and building on our strong foundation. UFP Technologies has highly talented people, trusted customer relationships, and many exciting market opportunities. I’m committed to continuing to execute our proven strategy to deliver long-term value for our customers, team members, and shareholders.”
About UFP Technologies, Inc.
UFP Technologies is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. UFP is a vital link in the medical device supply chain and a valued outsourcing partner to many of the world's top medical device manufacturers. The Company’s single-use and single-patient devices and components are used in a wide range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants.
Contact: Ron Lataille
978-234-0926, rlataille@ufpt.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.